Concepedia

Publication | Open Access

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

DOIFull Paper Access

36

Citations

33

References

2017

Year

Ruth Gostelow, Christopher Scudder, Sophie Keyte, Yaiza Forcada, Robert C. Fowkes, Herbert Schmid, David B. Church, Stijn Niessen
Journal of Veterinary Internal Medicine

Abstract

Pasireotide LAR is the first drug to show potential as a long-term management option for cats with HS.

References

YearCitations

Page 1